Puel A, Bastard P, Bustamante J, Casanova JL. Human autoantibodies underlying infectious diseases. J Exp Med. 2022;219(4):e20211387. https://doi.org/10.1084/jem.20211387.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ku CL, Chi CY, von Bernuth H, Doffinger R. Autoantibodies against cytokines: phenocopies of primary immunodeficiencies? Hum Genet. 2020;139:783–94. https://doi.org/10.1007/s00439-020-02180-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shih HP, Ding JY, Yeh CF, Chi CY, Ku CL. Anti-interferon-γ autoantibody-associated immunodeficiency. Curr Opin Immunol. 2021;72:206–14. https://doi.org/10.1016/j.coi.2021.05.007.

Article  CAS  PubMed  Google Scholar 

Vincent T, Plawecki MM, Goulabchand R, Guilpain P, Eliaou JFF. Emerging clinical phenotypes associated with anti-cytokine autoantibodies. Autoimmun Rev. 2015;14:528–35; https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=25633324&retmode=ref&cmd=prlinks

Casanova JL, Anderson MS. Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs. J Clin Invest. 2023;133(3):e166283. https://doi.org/10.1172/JCI166283.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ben-Dov I, Segel MJ. Autoimmune pulmonary alveolar proteinosis: clinical course and diagnostic criteria. Autoimmun Rev. 2014;13:513–7. https://linkinghub.elsevier.com/retrieve/pii/S1568997214000585.

Article  CAS  PubMed  Google Scholar 

Rosen LB, Freeman AF, Yang LM, Jutivorakool K, Olivier KN, Angkasekwinai N, et al. Anti–GM-CSF autoantibodies in patients with cryptococcal meningitis. J Immunol. 2013;190:3959–66. https://doi.org/10.4049/jimmunol.1202526. 

Article  CAS  PubMed  Google Scholar 

Saijo T, Chen J, Chen SC-ACA, Rosen LB, Yi J, Sorrell TC, et al. Anti-granulocyte-macrophage colony-stimulating factor autoantibodies are a risk factor for central nervous system infection by Cryptococcus gattii in otherwise immunocompetent patients. mBio. 2014;5:e00912–14. https://doi.org/10.1128/mBio.00912-14.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Crum-Cianflone NF, Lam PV, Ross-Walker S, Rosen LB, Holland SM. Autoantibodies to Granulocyte-Macrophage colony-stimulating factor Associated with severe and unusual manifestations of Cryptococcus gattii infections. Open Forum Infect Dis. 2017;4:1–6.

Article  Google Scholar 

Demir S, Chebib N, Thivolet-Bejui F, Cottin V. Pulmonary alveolar proteinosis following cryptococcal meningitis: a possible cause? BMJ Case Rep. 2018;2018:2017–9.

Google Scholar 

Huynh J, Saddi V, Cooper P, Cheng AT, Meyer W, Chen S, et al. Unusual presentation of severe endobronchial obstruction caused by Cryptococcus gattii in a child. J Pediatr Infect Dis Soc. 2019;9:67–70.

Article  Google Scholar 

Applen Clancey S, Ciccone EJ, Coelho MA, Davis J, Ding L, Betancourt R, et al. Cryptococcus deuterogattii vgiia infection associated with travel to the pacific northwest outbreak region in an anti- granulocyte-macrophage colony-stimulating factor autoantibody-positive patient in the United States. mBio. 2019;10:1–14.

Article  Google Scholar 

Stevenson B, Bundell C, Mulrennan S, McLean-Tooke A, Murray R, Brusch A. The significance of anti-granulocyte-macrophage colony-stimulating factor antibodies in cryptococcal infection: case series and review of antibody testing. Intern Med J. 2019;49:1446–50.

Article  PubMed  Google Scholar 

Lee E, Miller C, Ataya A, Wang T. Opportunistic Infection Associated With Elevated GM-CSF Autoantibodies: A Case Series and Review of the Literature. Open Forum Infect Dis. United States; 2022. p. ofac146.

Wang SY, Lo YF, Shih H-, Ho MW, Yeh CF, Peng JJ, et al. Cryptococcus gattii infection as the Major Clinical Manifestation in patients with autoantibodies against Granulocyte-Macrophage colony-stimulating factor. J Clin Immunol. 2022;42:1730–41.

Article  CAS  PubMed  Google Scholar 

Kuo PH, Wu UI, Pan YH, Wang JT, Wang YC, Sun HY, et al. Neutralizing anti-granulocyte-macrophage colony-stimulating factor autoantibodies in patients with Central Nervous System and localized cryptococcosis: Longitudinal Follow-Up and Literature Review. Clin Infect Dis. 2022;75:278–87.

Article  PubMed  Google Scholar 

Goupil de Bouillé J, Epelboin L, Henaff F, Migaud M, Abboud P, Blanchet D, et al. Case Report: Invasive Cryptococcosis in French Guiana: Immune and Genetic Investigation in six Non-HIV patients. Front Immunol. 2022;13:881352. https://doi.org/10.3389/fimmu.2022.881352.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Panackal AA, Rosen LB, Uzel G, Davis MJ, Hu G, Adeyemo A, et al. Susceptibility to Cryptococcal Meningoencephalitis Associated with idiopathic CD4(+) Lymphopenia and secondary germline or acquired defects. Open Forum Infect Dis. 2017;4:ofx082.

Article  PubMed  PubMed Central  Google Scholar 

Perrineau S, Guery R, Monnier D, Puel A, Lanternier F. Anti-GM-CSF autoantibodies and Cryptococcus neoformans var. Grubii CNS vasculitis. J Clin Immunol. 2020;40:767–9.

Article  PubMed  Google Scholar 

Viola GM, Malek AE, Rosen LB, DiNardo AR, Nishiguchi T, Okhuysen PC, et al. Disseminated cryptococcosis and anti-granulocyte-macrophage colony-stimulating factor autoantibodies: an underappreciated association. Mycoses. 2021;64:576–82.

Article  CAS  PubMed  Google Scholar 

Lim WT, Mudalige S, Nilushi T, Shanka J, Parakrama K. Crazy-paving pattern: a rare case of Autoimmune Pulmonary Alveolar Proteinosis (PAP) with positive Anti-GM-CSF antibody following cryptococcal infection in an otherwise Healthy Individual and Review of Literature. Eur J Respiratory Med. 2021;3:200–5.

Google Scholar 

Arango-Franco CA, Migaud M, Ramírez-Sánchez IC, Arango-Bustamante K, Moncada-Vélez M, Rojas J, et al. Anti-GM-CSF neutralizing autoantibodies in Colombian patients with disseminated cryptococcosis. J Clin Immunol. 2023;43:921–32.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuo CY, Wang SY, Shih HP, Tu KH, Huang WC, Ding JY, et al. Disseminated Cryptococcosis due to anti-granulocyte-macrophage colony-stimulating factor autoantibodies in the absence of pulmonary alveolar proteinosis. J Clin Immunol. 2017;37:143–52.

Article  CAS  PubMed  Google Scholar 

Yang DH, England MR, Salvator H, Anjum S, Park YD, Marr KA, et al. Cryptococcus Gattii Species Complex as an opportunistic Pathogen: Underlying Medical conditions Associated with the infection. mBio. 2021;12:e0270821.

Article  PubMed  Google Scholar 

Rosen LB, Rocha Pereira N, Figueiredo CCC, Fiske LC, Ressner RA, Hong JC, et al. Nocardia-induced granulocyte macrophage colony-stimulating factor is neutralized by autoantibodies in disseminated/extrapulmonary nocardiosis. Clin Infect Dis. 2015;60:1017–25. https://doi.org/10.1093/cid/ciu968.

Article  CAS  PubMed  Google Scholar 

Salvator H, Cheng A, Rosen LB, Williamson PR, Bennett JE, Kashyap A, et al. Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis. Respir Res. 2022;23:1–9. https://doi.org/10.1186/s12931-022-02103-9.

Article  CAS  Google Scholar 

Wu X-KK, Lin Q. Pulmonary alveolar proteinosis complicated with nocardiosis: a case report and review of the literature. World J Clin Cases. 2021;9:2874–83.

Article  PubMed  PubMed Central  Google Scholar 

Berthoux C, Mailhe M, Vély F, Gauthier C, Mège JL, Lagier JC, et al. Granulocyte Macrophage colony-stimulating factor-specific autoantibodies and cerebral Nocardia with Pulmonary Alveolar Proteinosis. Open Forum Infect Dis. 2021;8:1–5.

Article  Google Scholar 

Mehta HH, Shamoo Y. Pathogenic nocardia: a diverse genus of emerging pathogens or just poorly recognized? PLoS Pathog. 2020;16:1–7.

Article  Google Scholar 

Lerner PI, Nocardiosis. Clin Infect Dis. 1996;22:891–5.

Article  CAS  PubMed  Google Scholar 

Inoue Y, Trapnell BC, Tazawa R, Arai T, Takada T, Hizawa N, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med. 2008;177:752–62.

Article  PubMed  PubMed Central  Google Scholar 

Chi CY, Chu CC, Liu JP, Lin CH, Ho MW, Lo WJ, et al. Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121:1357–66. https://doi.org/10.1182/blood-2012-08-452482.

Article  CAS  PubMed